Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.

Ito H, Maemoto T, Akahane A, Butcher SP, Olverman HJ, Finlayson K.

Eur J Pharmacol. 1999 Jan 22;365(2-3):309-15.

PMID:
9988116
2.

Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.

Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.

Br J Pharmacol. 1997 Nov;122(6):1202-8.

3.

Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.

Br J Pharmacol. 1996 Apr;117(7):1381-6.

4.

Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.

Marston HM, Finlayson K, Maemoto T, Olverman HJ, Akahane A, Sharkey J, Butcher SP.

J Pharmacol Exp Ther. 1998 Jun;285(3):1023-30.

5.
6.

G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.

Cunha RA, Constantino MD, Ribeiro JA.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Apr;359(4):295-302.

PMID:
10344528
7.

A novel non-xanthine adenosine A1 receptor antagonist.

Terai T, Kita Y, Kusunoki T, Shimazaki T, Ando T, Horiai H, Akahane A, Shiokawa Y, Yoshida K.

Eur J Pharmacol. 1995 Jun 12;279(2-3):217-25.

PMID:
7556404
8.

Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine.

Moore RJ, Xiao R, Sim-Selley LJ, Childers SR.

Neuropharmacology. 2000 Jan 4;39(2):282-9.

PMID:
10670423
9.

Biological activities of N6,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A1 receptors.

Lorenzen A, Sebastião AM, Sellink A, Vogt H, Schwabe U, Ribeiro JA, IJzerman AP.

Eur J Pharmacol. 1997 Sep 10;334(2-3):299-307.

PMID:
9369361
10.

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.

Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.

Br J Pharmacol. 1997 Jun;121(3):353-60.

12.

5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.

Odagaki Y, Toyoshima R.

Eur J Pharmacol. 2005 Oct 3;521(1-3):49-58. Epub 2005 Sep 21.

PMID:
16182280
13.
14.

Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.

De Sarro G, De Sarro A, Di Paola ED, Bertorelli R.

Eur J Pharmacol. 1999 Apr 29;371(2-3):137-45.

PMID:
10357250
15.

Activation of various subtypes of G-protein alpha subunits by partial agonists of the adenosine A1 receptor.

Lorenzen A, Lang H, Schwabe U.

Biochem Pharmacol. 1998 Nov 15;56(10):1287-93.

PMID:
9825727
16.

5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.

van Tilburg EW, van der Klein PA, von Frijtag Drabbe Künzel J, de Groote M, Stannek C, Lorenzen A, IJzerman AP.

J Med Chem. 2001 Aug 30;44(18):2966-75.

PMID:
11520205
17.

Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain.

Childers SR, Li X, Xiao R, Eisenach JC.

J Neurochem. 2005 May;93(3):715-23.

18.

Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor.

Volpini R, Costanzi S, Lambertucci C, Vittori S, Klotz K, Lorenzen A, Cristalli G.

Bioorg Med Chem Lett. 2001 Jul 23;11(14):1931-4.

PMID:
11459663
19.

Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.

Odagaki Y, Kinoshita M, Toyoshima R.

Basic Clin Pharmacol Toxicol. 2011 Sep;109(3):175-85. doi: 10.1111/j.1742-7843.2011.00705.x. Epub 2011 May 5.

20.

Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.

Nonaka H, Mori A, Ichimura M, Shindou T, Yanagawa K, Shimada J, Kase H.

Mol Pharmacol. 1994 Nov;46(5):817-22.

PMID:
7969067

Supplemental Content

Support Center